Académique Documents
Professionnel Documents
Culture Documents
21. Cheng BC, Chang WN, Lu CH, Chen JB, Chang CS, Lee CH. Bacterial meningitis in
hemodialyzed patients.J Nephrol. Mar-Apr 2004;17(2):236-41.
22. Arieff AI, Mahoney CA. Pathogenesis of dialysis encephalopathy. Neurobehav Toxicol Teratol.
Nov-Dec 1983;5(6):641-4.
23. Balzer S, Kuttner K. [Early auditory evoked potential. A diagnostic parameter in uremic
encephalopathy].HNO. Oct 1996;44(10):559-66.
24. Biasioli S, D'Andrea G, Chiaramonte S, Fabris A, Feriani M, Ronco C, et al. The role of
neurotransmitters in the genesis of uremic encephalopathy. Int J Artif Organs. Mar 1984;7(2):1016.
25. Biasioli S, D'Andrea G, Fabris A, Feriani M, La Greca G. The pathogenesis of uremic
encephalopathy (UE).Int J Artif Organs. Jan 1985;8(1):59-60.
26. Bolton CF, Young GB. Uremic encephalopathy. In: Neurological Complications of Renal Disease.
Boston, MA: Butterworths; 1990:43-74.
27. Bourne JR, Teschan PE. Computer methods, uremic encephalopathy, and adequacy of
dialysis. Kidney Int. Oct 1983;24(4):496-506.
28. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol
Neurosurg. Dec 2004;107(1):1-16.
29. Chiappa KH, Hill RA. Evoked Potentials in Clinical Medicine. 3rd ed. Philadelphia, PA: Lippincott
Williams & Wilkins; 1997.
30. Chow KM, Wang AY, Hui AC, Wong TY, Szeto CC, Li PK. Nonconvulsive status epilepticus in
peritoneal dialysis patients. Am J Kidney Dis. Aug 2001;38(2):400-5.
31. De Deyn PP, Saxena VK, Abts H, et al. Clinical and pathophysiological aspects of neurologic
complications in renal failure. Acta Neurol Belg. 1992;92:191-206.
32. De Deyn PP, Vanholder R, D'Hooge R. Nitric oxide in uremia: effects of several potentially toxic
guanidino compounds. Kidney Int Suppl. May 2003;S25-8.
33. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis
modality among incident ESRD patients with and without coronary artery disease. J Am Soc
Nephrol. Feb 2003;14(2):415-24.
34. Habach G, Bloembergen WE, Mauger EA, Wolfe RA, Port FK. Hospitalization among United
States dialysis patients: hemodialysis versus peritoneal dialysis. J Am Soc Nephrol. May
1995;5(11):1940-8.
35. Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and
unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis.
Nov 2001;38(5):941-7.
36. Jagadha V, Deck JH, Halliday WC, Smyth HS. Wernicke's encephalopathy in patients on
peritoneal dialysis or hemodialysis. Ann Neurol. Jan 1987;21(1):78-84.
37. Jeppsson B, Freund HR, Gimmon Z, et al. Blood-brain barrier derangement in uremic
encephalopathy.Surgery. Jul 1982;92(1):30-5.
38. Kiley JE, Pratt KL, Gisser DG, Schaffer CA. Techniques of EEG frequency analysis for evaluation
of uremic encephalopathy. Clin Nephrol. Jun 1976;5(6):279-85.
39. Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, et al. Acute kidney injury leads to
inflammation and functional changes in the brain. J Am Soc Nephrol. Jul 2008;19(7):1360-70.
40. Lockwood AH. Neurologic complications of renal disease. Neurol Clin. Aug 1989;7(3):617-27.
41. Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental
features. Am J Kidney Dis. Nov 1982;2(3):324-36.
42. Moe SM, Sprague SM. Uremic encephalopathy. Clin Nephrol. Oct 1994;42(4):251-6.
43. Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barr P, et al. Comparative
hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney Int. Jun
2000;57(6):2557-63.
44. Niedermeyer E. Metabolic central nervous system disorders. In: Basic Principles, Clinical
Applications, and Related Fields. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins;
1993:405-18.
45. Norenberg MD, Bruce-Gregorios J. Renal disease. In: Textbook of Neuropathology. 3rd ed.
Philadelphia, PA: Lippincott Williams & Wilkins; 1997:575-9.
46. Ropper AH, Brown RH. Uremic encephalopathy. In: Adams and Victor's Principles of Neurology.
8th ed. New York, NY: McGraw-Hill Professional; 2005:969-71.
47. Schmidt M, Sitter T, Lederer SR, et al. Reversible MRI changes in a patient with uremic
encephalopathy. J Nephrol. Sep-Oct 2001;14(5):424-7.
48. Souheaver GT, Ryan JJ, DeWolfe AS. Neuropsychological patterns in uremia. J Clin Psychol. Jul
1982;38(3):490-6.
49. Topczewska-Bruns J, Pawlak D, Chabielska E, et al. Increased levels of 3-hydroxykynurenine in
different brain regions of rats with chronic renal insufficiency. Brain Res Bull. Aug 15
2002;58(4):423-8.
50. Wu AW, Fink NE, Marsh-Manzi JV, Meyer KB, Finkelstein FO, Chapman MM, et al. Changes in
quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific
measures. J Am Soc Nephrol. Mar 2004;15(3):743-53.
51. Zucker I, Yosipovitch G, David M, et al. Prevalence and characterization of uremic pruritus in
patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with endstage renal disease. J Am Acad Dermatol. Nov 2003;49(5):842-6.
52. Toyin F. Olatinwo, MD, Ross G. Hewitt, MD. New Onset Seizures as an Initial Presentation of
End-Stage Renal Failure in Patients With HIV/AIDS. AIDS Read. 2002;12(6).
53. Steven Jay Rosansky, William F. Clark, Paul Eggers, Richard J. Glassock. Initiation of Dialysis at
Higher GFRs: Is the Apparent Rising Tide of Early Dialysis Harmful or Helpful?. Kidney
Int. 2009;76(3):257261.
54. Anyzeila Diaz, Beverly Deliz, Selim R Benbadis. The Use of Newer Antiepileptic Drugs in Patients
With Renal Failure. Expert Rev Neurother. 2012;12(1):99-105.
55. Pamela Wratchford, Charles D. Ponte. High-Dose Simvastatin and Rhabdomyolysis. Am J Health
Syst Pharm. 2003;60(7)